NewsBenzingaHC Wainwright & Co. 重申对 Tango Therapeutics 的“买入”评级，并维持 68 美元目标价 HC Wainwright & Co. 重申对 Tango Therapeutics 的“买入”评级，并维持 68 美元目标价 Benzinga 2026.10.29 10:22 (GMT+0) Open on Benzinga Other news Hyatt Bets on Luxury, Wins Big and Raises 2026 Growth Outlook Stifel Maintains Hold on Avantor, Raises Price Target to $18 BTIG Maintains Buy on Fortinet, Lowers Price Target to $186 Stifel Maintains Hold on Automatic Data Processing, Raises Price Target to $305 Bunge Expects Multi-Oil Refinery In The Netherlands To Start Up In Q1 2027; Expects To Use More Working Capital Than The Prior Year; Brazil Currency Moves Since Election Lowered Some Costs, Increased Farmer Selling Scott Bessent Brushes Off Concerns Over AI Debt Amid CoreWeave Slump, Calls Neoclouds a ‘Small Component’
Bunge Expects Multi-Oil Refinery In The Netherlands To Start Up In Q1 2027; Expects To Use More Working Capital Than The Prior Year; Brazil Currency Moves Since Election Lowered Some Costs, Increased Farmer Selling
Scott Bessent Brushes Off Concerns Over AI Debt Amid CoreWeave Slump, Calls Neoclouds a ‘Small Component’
